Clik here to view.
Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based...
KOBE, Japan & BURLINGTON, N.C. Sysmex Corporation (TSE:6869) and Laboratory Corporation of America® Holdings (LabCorp®) (LH:NYSE) today announced a strategic collaboration focused on the...
View ArticleClik here to view.
Hanmi Pharmaceutical ‘HM61713’ Demonstrated the Effect of Tumor Volume Reduction
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd. (KSE:128940) presented the interim results of phase I/II domestic clinical trial on HM61713 at the 51st American Society of Clinical Oncology (ASCO)...
View ArticleClik here to view.
Novacyt and Leica Biosystems Launch NOVAprep® in China
PARIS & CAMBRIDGE, England Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics and Leica Biosystems, a leading supplier to the pathology market,...
View ArticleClik here to view.
Latest Brainlab software for treatment of brain metastases and benign skull...
YOKOHAMA, Japan Experts in stereotactic radiosurgery (SRS) from all over the globe will be presenting Brainlab software innovations at this year’s International Stereotactic Radiosurgery Society...
View ArticleClik here to view.
エリテックがASCOでGRASPA®の第III相（ALL）の完全な結果を報告し、第IIb相（AML）の最新情報を提供
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（ADR:EYRYY）（Euronext Paris – ERYP; OTC US –...
View ArticleClik here to view.
Guided Therapeutics Awarded Multiple Tenders for LuViva® Advanced Cervical...
DHAKA, Bangladesh Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) announced today that its distributor in Bangladesh has been awarded contracts for four additional LuViva® Advanced Cervical...
View ArticleClik here to view.
CEL-SCI is Cleared to Start Patient Enrollment for Its Phase 3 Cancer...
VIENNA, Va. CEL-SCI Corporation (NYSE MKT: CVM) (“CEL SCI” or the “Company”) today announced that CEL-SCI is now cleared to start patient enrollment in Thailand in its ongoing Phase 3 trial with its...
View ArticleClik here to view.
Elekta CE Marks Leksell Gamma Knife® Icon™, designed to treat a more...
STOCKHOLM, Sweden Regulatory News: Elekta has CE marked its Leksell Gamma Knife® Icon™ (http://www.careforthebrain.com/) precision radiosurgery system, making this latest generation Leksell Gamma...
View ArticleClik here to view.
Oral Presentation Evaluating Pooled Data on OTEZLA® (apremilast) for...
BOUDRY, Switzerland Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that the findings from a long-term (104-week) post-hoc analysis of...
View ArticleClik here to view.
Annoroad and Illumina to Co-Develop NGS Diagnostic System for Reproductive...
BEIJING & SAN DIEGO Annoroad and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement to jointly develop advanced clinical applications for reproductive health based...
View ArticleClik here to view.
Sibley Memorial Hospital Selects Hitachi for Their Proton Beam Therapy System...
TOKYO Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced that Johns Hopkins Medicine has selected Hitachi to provide its proton beam therapy (PBT) system at Sibley Memorial Hospital located in...
View ArticleClik here to view.
Pharma Sales Forecast to Grow 5% Annually Through to 2020, Industry’s R&D...
LONDON & BOSTON & TOKYO Life science market intelligence firm, Evaluate Ltd, is launching their annual complimentary industry report, “EvaluatePharma World Preview 2015, Outlook to 2020,” at...
View ArticleClik here to view.
Medivir: Increased Focus within Medivir’s R&D and Optimizing Resources...
STOCKHOLM Regulatory News: Medivir (STO:MVIRB) Medivir AB (Nasdaq Stockholm: MVIR) today announces a reorganization within its Discovery Research department, increasing its focus within the core...
View ArticleClik here to view.
エリテックが2件の肯定的なDSMB評価結果を発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（ADR:EYRYY）（Euronext Paris – ERYP; OTC US –...
View ArticleClik here to view.
Overcoming Challenges in Sequence Analysis of FFPE Tissue Due to...
BOLOGNA, Italy Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company that is part of the pharmaceutical Menarini Group, presented recent findings obtained with its...
View ArticleClik here to view.
GenesisCare Acquires Cancer Partners UK – Cancer Patients to Benefit from...
SYDNEY GenesisCare, Australia’s largest provider of radiotherapy services (GenesisCare), today announced the acquisition of the United Kingdom’s leading provider of private cancer services, Cancer...
View ArticleClik here to view.
NuGEN Scientists Screen 400+ Genes for Fusion Events in Single Assay; Detect...
SAN CARLOS, Calif. Scientists at NuGEN Technologies, Inc. have simultaneously surveyed RNA of more than 400 targeted genes in a single assay, using next generation sequencing (NGS) to detect fusions...
View ArticleClik here to view.
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
Provectus Biopharmaceuticals’ Phase 1 PV-10 Data on Liver Cancer Presented at...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
Investigation Finds Asbestos Fibers in Crayons and Toys from China
WASHINGTON The Asbestos Disease Awareness Organization (ADAO), which combines education, advocacy, and community to prevent exposure and ensure justice for asbestos victims, is outraged by the...
View Article